Driehaus Capital Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$31.7 - $69.93 $634,000 - $1.4 Million	-20,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $399,000 - $777,000	20,000 New	20,000 $679,000
Q2 2019 Aug 14, 2019	SELL	$21.05 - $26.21 $3.16 Million - $3.93 Million	-150,123 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $662,142 - $947,520	-32,065 Reduced 17.6%	150,123 $3.48 Million
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $1.16 Million - $2.2 Million	-60,923 Reduced 25.06%	182,188 $3.82 Million
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $258,992 - $324,801	7,715 Added 3.28%	243,111 $9.41 Million
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $4.72 Million - $10.6 Million	235,396 New	235,396 $9.26 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.